Dawson, Ted M.
Johns Hopkins University
60 papers on CoChatORCID 0000-0002-6459-0893
Most cited papers
- Verified
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease
Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Ryu, T., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., et al. (2023) · Science Translational Medicine
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 64
- Verified
Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological α-synuclein
Sterling, J. K., Kam, T.-I., Guttha, S., Park, H., Baumann, B., Mehrabani-Tabari, A. A., Schultz, H., Anderson, B., Alnemri, A., Chou, S.-C., et al. (2022) · Cell Reports
Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism
Cited by 58
- Verified
Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis
Kim, J. W., Yin, X., Jhaldiyal, A., Khan, M. R., Martin, I., Xie, Z., Perez-Rosello, T., Kumar, M., Abalde-Atristain, L., Xu, J., et al. (2020) · Cell Stem Cell
Parkinson's Disease Mechanisms and TreatmentsRNA and protein synthesis mechanisms
Cited by 56
- Verified
Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
Hinkle, J. T., Perepezko, K., Mills, K. A., Mari, Z., Butala, A., Dawson, T. M., Pantelyat, A., Rosenthal, L. S., & Pontone, G. M. (2018) · Parkinsonism & Related Disorders
Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders
Cited by 49
- Verified
Assessment of APOE in atypical parkinsonism syndromes
Sabir, M. S., Blauwendraat, C., Ahmed, S., Serrano, G. E., Beach, T. G., Perkins, M., Rice, A. C., Masliah, E., Morris, C. M., Pihlstrom, L., et al. (2019) · Neurobiology of Disease
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 28
- Verified
The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives
Gharagozloo, M., Galleguillos, D., Jank, L., Sotirchos, E. S., Smith, M. D., Garton, T., Kumar, S., Hussein, O., Potluri, S., Taylor, M., et al. (2023) · Neurotherapeutics
Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanisms
Cited by 23
- Verified
Endonuclease G does not play an obligatory role in poly(ADP-ribose) polymerase-dependent cell death after transient focal cerebral ischemia
Xu, Z., Zhang, J., David, K. K., Yang, Z.-J., Li, X., Dawson, T. M., Dawson, V. L., & Koehler, R. C. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Cell death mechanisms and regulationPARP inhibition in cancer therapy
Cited by 20
- Verified
What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Liang, D., Dawson, T., & Dawson, V. (2004) · Current Molecular Medicine
Acute Ischemic Stroke ManagementNeuroprotection in Cerebral Ischemia
Cited by 18
- Verified
Non-autonomous cell death in Parkinson's disease
Dawson, T. M. (2008) · The Lancet Neurology
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 16
- Verified
CYFIP1 Dosages Exhibit Divergent Behavioral Impact via Diametric Regulation of NMDA Receptor Complex Translation in Mouse Models of Psychiatric Disorders
Kim, N.-S., Ringeling, F. R., Zhou, Y., Nguyen, H. N., Temme, S. J., Lin, Y.-T., Eacker, S., Dawson, V. L., Dawson, T. M., Xiao, B., et al. (2022) · Biological Psychiatry
Genetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalities
Cited by 15
- Verified
A new Perspective on Parkinson's disease: exploring the involvement of intestine and vagus lysates in α-synucleinopathy propagation
Ullah, R., Dawson, V. L., & Dawson, T. M. (2023) · Ageing and Neurodegenerative Diseases
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 4
- Verified
Enhanced mTORC1 signaling and Protein Synthesis in Parkinson’s Disease Pathogenesis Disease Pathogenesis
Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., Kim, H. H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory)
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free